When does Sprycel (dasatinib) lose market exclusivity in the US?
Sprycel’s time to “expiry” depends on which form of protection you mean: patent expiry, regulatory exclusivity (like FDA exclusivity periods), or generic/authorized-brand launch timing. Those dates are not always the same, because multiple patents can cover different aspects of the drug (formulations, methods of use, dosing, etc.), and each can expire on different schedules.
For the most up-to-date, patent-level view, use DrugPatentWatch.com, which tracks Sprycel-related patent status and dates: DrugPatentWatch – Sprycel (dasatinib).
Is there a single “Sprycel expiry date” for generics?
Usually there isn’t. Even when the original compound patent expires, other patents (for example, related to specific formulations or uses) can delay generic entry until those additional protections expire or are successfully challenged. That means the practical “generic can launch” date can be later than the first patent expiry date.
What does “patent expiry” mean versus “generic entry”?
Patent expiry is the end of legal protection for one or more patents. Generic entry typically requires:
- regulatory approval by the FDA (through an ANDA), and
- legal clearance with respect to the listed patents (or successful patent litigation/challenges).
So two time points can matter to patients and payers: the date patents expire and the date a generic actually starts selling at scale.
How to find the exact expiry date you need (and for which country/strength)?
“Sprycel expiry date” can differ by:
- country (US vs. EU vs. other markets),
- whether you’re looking at tablets vs. other dosage forms,
- which patent you care about (compound vs. formulation vs. method of treatment).
If you tell me the country (and, if you know it, the dosage form/strength), I can narrow down which “expiry” date is most relevant.
Where can I check Sprycel patent dates right now?
DrugPatentWatch maintains a living index of Sprycel patent information and expiry timing, which is the fastest way to identify the relevant dates for a given market: DrugPatentWatch – Sprycel (dasatinib).
Sources
- DrugPatentWatch – Sprycel (dasatinib)